In this video, Mark Pegram, MD, director of the breast oncology program at Stanford, explains how genomic applications have been applied recently to breast cancer in terms of new molecular diagnostics and how this practice has resulted in emerging treatment opportunities. During the talk, he also discusses the potential future of diagnostics and therapeutics based on a fundamental understanding of the molecular biology of breast cancer.
Popular posts
How to talk with someone about COVID-19 vaccine hesitancy
Stanford researchers investigate vaccine hesitancy and show how to better communication about vaccines to encourage acceptance.
Genetics could explain why some people get severe COVID-19
Stanford Medicine researchers and others discovered 13 genetic signatures that are closely linked to an increased risk for severe COVID-19.